MktsMarkets

Adaptive Biotechnologies Corporation
NASDAQ: ADPTKey statistics
ADPT News
Stories mentioning ADPT from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 70,874 | 71,681 | 93,973 | 58,879 | 52,443 | 47,459 | 46,435 | 43,190 |
| Cost of Goods Sold | 18,708 | 18,224 | 18,157 | 17,999 | 16,979 | 18,045 | 16,667 | 19,317 |
| Gross Profit | 52,166 | 53,457 | 75,816 | 40,880 | 35,464 | 29,414 | 29,768 | 23,873 |
| Operating Expenses | ||||||||
| Research & Development | 23,623 | 21,763 | 23,669 | 24,134 | 24,203 | 23,192 | 24,163 | 25,353 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (19,206) | (12,773) | 10,290 | (25,036) | (29,604) | (33,837) | (32,632) | (47,318) |
| Interest Income | ||||||||
| Interest Expense | 2,889 | 2,954 | 2,971 | 2,948 | 2,905 | 2,952 | 2,939 | 2,696 |
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (20,033) | (13,579) | 9,546 | (25,614) | (29,852) | (33,692) | (32,071) | (46,222) |
| Earnings Per Share (Basic) | (0.13) | (0.09) | 0.06 | (0.17) | (0.20) | (0.23) | (0.22) | (0.31) |
| Earnings Per Share (Diluted) | (0.13) | (0.09) | 0.06 | (0.17) | (0.20) | (0.23) | (0.22) | (0.31) |
| Weighted Average Shares Outstanding (Basic) | 155,521 | 151,722 | 152,432 | 152,082 | 149,195 | 147,102 | 147,516 | 147,414 |
| Weighted Average Shares Outstanding (Diluted) | 155,521 | 151,722 | 163,162 | 152,082 | 149,195 | 147,102 | 147,516 | 147,414 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ADPT
Adaptive Biotechnologies Corporation (NASDAQ: ADPT) is a stock listed on the Nasdaq Stock Market under the ticker symbol ADPT. It last traded at $29.04 (Nov 13, 2026, 9:30 AM ET), down 1.5% on the day. That gives Adaptive Biotechnologies a market capitalisation of $4.8B.
Over the past 52 weeks ADPT has traded between $12.00 and $32.21.
Revenue for the quarter ended Mar 31, 2026 was $70.9M; a net loss of $20.0M. Revenue was up 35.1% from $52.4M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $70.9M | -$20.0M | -28.3% |
| Dec 31, 2025 | $71.7M | -$13.6M | -18.9% |
| Sep 30, 2025 | $94.0M | $9.5M | 10.2% |
| Jun 30, 2025 | $58.9M | -$25.6M | -43.5% |
From Adaptive Biotechnologies’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…